Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

KORANDIL 5 TABLET 5 MG - HSA Drug Approval Details

Approvals/HSA/KORANDIL 5 TABLET 5 MG

Approved

THERAPEUTIC

KORANDIL 5 TABLET 5 MG

REMEDICA LTD (CYPRUS)🇸🇬 Health Sciences Authority

Approval Date: Mar 10, 1994
Approval ID: eded97c9577c834b
Company: REMEDICA LTD (CYPRUS)
Type: Therapeutic

Approval Details

Approval Id: eded97c9577c834b
Drug Name: KORANDIL 5 TABLET 5 MG
Product Name: KORANDIL 5 TABLET 5 MG
Approval Number: SIN07657P
Approval Date: 1994-03-10
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Licence Holder: GOLDPLUS UNIVERSAL PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: C09AA02
Atc Item Name: enalapril
Pharma Manufacturer Name: GOLDPLUS UNIVERSAL PTE LTD

Active Ingredients

ENALAPRIL MALEATE

5 mg

ENALAPRIL MALEATE

5 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 10, 1994

Approval ID

eded97c9577c834b

Type

Therapeutic

Back to HSA Approvals